Safety and tolerability study of MEDI0382 in Japanese preobese or obese subjects with type 2 diabetes

Trial Identifier: D5674C00001
Sponsor: AstraZeneca
NCTID:: NCT03645421
Start Date: August 2018
Primary Completion Date: January 2019
Condition: Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
Japanese Translation

Trial Locations

Country Location
Japan Chuo-ku, Japan, 103-0027
Japan Chuo-ku, Japan, 104-0031
Japan Shinjuku-ku, Japan, 160-0008
Japan Shinjuku-ku, Japan, 162-0053
Japan Suita-shi, Japan, 565-0853